PlainRecalls
FDA Drug Low Class III Terminated

Clonazepam Orally Disintegrating Tablets, USP, 0.125 mg, 60-count bottle, Rx only, Mfg by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, NDC 57664-783-86

Reported: August 5, 2020 Initiated: July 6, 2020 #D-1445-2020

Product Description

Clonazepam Orally Disintegrating Tablets, USP, 0.125 mg, 60-count bottle, Rx only, Mfg by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, NDC 57664-783-86

Reason for Recall

Cross contamination with other products - OOS discovered during routine stability testing for highest unknown impurity later identified as clozapine

Details

Units Affected
3516 bottles
Distribution
Nationwide USA
Location
Princeton, NJ

Frequently Asked Questions

What product was recalled?
Clonazepam Orally Disintegrating Tablets, USP, 0.125 mg, 60-count bottle, Rx only, Mfg by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, NDC 57664-783-86. Recalled by SUN PHARMACEUTICAL INDUSTRIES INC. Units affected: 3516 bottles.
Why was this product recalled?
Cross contamination with other products - OOS discovered during routine stability testing for highest unknown impurity later identified as clozapine
Which agency issued this recall?
This recall was issued by the FDA Drug on August 5, 2020. Severity: Low. Recall number: D-1445-2020.